About PL BioScience
PL BioScience is a company based in Aachen (Germany) founded in 2015. PL BioScience has raised $13.03 million across 2 funding rounds from investors including Lepure Biotech, AVANT BIO and b.value. PL BioScience offers products and services including ELAREM™ Prime, ELAREM™ Perform, ELAREM™ Ultimate, and ELAREM™ Matrix Kit. PL BioScience operates in a competitive market with competitors including Abcam, Stem Cell Technologies, BioLife Solutions, RoosterBio and Shanghai Doning Biotechnology, among others.
- Headquarter Aachen, Germany
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pl Bioscience Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.03 M (USD)
in 2 rounds
-
Latest Funding Round
$8.51 M (USD), Series A
Aug 11, 2024
-
Investors
Lepure Biotech
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PL BioScience
PL BioScience offers a comprehensive portfolio of products and services, including ELAREM™ Prime, ELAREM™ Perform, ELAREM™ Ultimate, and ELAREM™ Matrix Kit.
Animal-free substitute for Fetal Bovine Serum in academic research
Supports pre-clinical stem cell expansion with enhanced growth factors
Virus-inactivated option for therapeutic applications in cell therapy
Hydrogel for 3D cultivation and isolation of mesenchymal stem cells
Funding Insights of PL BioScience
PL BioScience has successfully raised a total of $13.03M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $8.51 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $8.5M
-
First Round
First Round
(25 May 2021)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series A - PL BioScience | Valuation | AVANT BIO , Lepure Biotech |
|
| May, 2021 | Amount | Series A - PL BioScience | Valuation | Brightlands Venture Partners , Born2Grow |
|
Investors in PL BioScience
PL BioScience has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Lepure Biotech, AVANT BIO and b.value.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment is made by AVANT BIO in life sciences technologies.
|
Founded Year | Domain | Location | |
|
DeepTech startups are financed and supported by b.value AG.
|
Founded Year | Domain | Location | |
|
Micro-venture capital firm investing in pre-seed to seed stage startups
|
Founded Year | Domain | Location |
Investments & Acquisitions by PL BioScience
Financial Statements - PL BioScience
Pl Bioscience Comparisons
Competitors of PL BioScience
PL BioScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, BioLife Solutions, RoosterBio and Shanghai Doning Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| domain | founded_year | HQ Location |
Developer of human mesenchymal stem cells and extracellular vesicles
|
|
| domain | founded_year | HQ Location |
Serum-free cell culture media is supplied to biopharmaceutical industries.
|
|
| domain | founded_year | HQ Location |
Transfection Solutions for Healthcare and Life Sciences organizations
|
Frequently Asked Questions about PL BioScience
PL BioScience was founded in 2015 and raised its 1st funding round 6 years after it was founded.
PL BioScience is headquartered in Aachen, Germany. It is registered at Aachen, North Rhine-westphalia, Germany.
Hatim Hemeda is the current CEO of PL BioScience.
PL BioScience is a funded company, having raised a total of $13.03M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.51M, raised on May 25, 2021.
PL BioScience was founded in 2015 in Aachen, Germany, within the biotechnology sector. Cell culture products, including platelet lysate and xeno-free media, are developed for stem cell expansion in research and clinical settings. A 3D cell culture system enriched with platelet-derived growth factors is also offered to support cellular therapeutics development and implementation. Operations focus on solutions for both research and clinical applications.
PL BioScience's top competitors include Abcam, RoosterBio and BioLife Solutions.
PL BioScience offers ELAREM™ Prime, ELAREM™ Perform, ELAREM™ Ultimate, and ELAREM™ Matrix Kit.
PL BioScience has 8 investors. Key investors include Lepure Biotech, AVANT BIO, b.value, Better Ventures, and Brightlands Venture Partners.